Data as of Apr 17
| +0.16 / +0.83%|
The 5 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 42.00 and a low estimate of 26.00. The median estimate represents a +69.75% increase from the last price of 19.44.
The current consensus among 5 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.